What to expect from Roche's readout on experimental Alzheimer's drug; CDC sees signs of early start to flu season

The Swiss pharma giant will announce results from a pair of clinical studies of gantenerumab within the next six weeks. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      STAT+: What to know about Roche's experimental Alzheimer's treatment By Adam Feuerstein and Damian Garde Sebastien Bozon/AFP via Getty Images Interest in the readout on gantenerumab has heightened since drugmakers Eisai and Biogen announced positive results for lecanemab. Read More CDC: Signs point to an early start for flu season, with cases already ticking up in parts of the U.S. By Helen Branswell Virginia Mayo/AP A conversation with Lynnette Brammer, a CDC flu epidemiologist, suggests that the U.S. flu season is off to an early start. Read More STAT+: Josh Bilenker's last biotech sold for $8 billion. His next one is cloaked in mystery but loaded with money By Matthew Herper and Allison DeAngelis AP Photo/Ted S. Warren Josh Bilenker sold his last company to Eli Lilly for $8 billion. His next effort, Treeline, has already raised nearly $475 million. Read More Sponsored Insight by AWS MARKETPLACE Collecting and harmonizing real-world data Join this webinar to hear from data leaders at AWS, Qiagen, TriNetX and Prognos, as they discuss how real-world data is integral to ensuring patient health. You'll learn how leveraging insights from real-world data as part of a wider data strategy can help to gain critical patient insights. Register now. STAT+: Milestone Pharma's nasal spray rapidly restores normal heart rhythm, achieving goal of key study By Adam Feuerstein Adobe Results of a study announced on Monday show etripamil to be an effective treatment for paroxysmal supraventricular tachycardia. Read More Opinion: Polio eradication is in sight. Don't stop funding it now By Seth Berkley K.M. Chaudary/AP The Global Polio Eradication Initiative has driven down the global number of polio cases by 99.9%. It needs funding to finish the job. Read More STAT+: European Prosecutor's Office confirms it's investigating European Union Covid vaccine contracts By Ed Silverman Cindy Ord/Getty Images for Pfizer/BioNTech The probe heightens controversy over European Commission President Ursula von der Leyen and her role in a vaccine contract with Pfizer. Read More Monday, October 17, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser